Rani Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $2,750 |
Gross Profit | -255 | -248 | 2,523 |
EBITDA | -11,830 | -13,237 | -12,532 |
EBIT | -12,085 | -13,485 | -12,759 |
Net Income | -6,805 | -7,483 | -7,098 |
Net Change In Cash | 0 | 0 | 2,750 |
Free Cash Flow | -9,123 | -9,420 | -12,645 |
Cash | 4,514 | 7,377 | 6,364 |
Basic Shares | 26,324 | 26,034 | 25,874 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2,717 | $462 |
Gross Profit | -822 | -1,312 | 2,717 | 462 |
EBITDA | -65,277 | -60,891 | -52,084 | -15,955 |
EBIT | -66,099 | -62,203 | -52,581 | -16,544 |
Net Income | -33,970 | -63,344 | -53,088 | -16,703 |
Net Change In Cash | 0 | 0 | 2,717 | 462 |
Cost of Revenue | -89,946 | |||
Free Cash Flow | -52,465 | -48,134 | -32,751 | -16,160 |
Cash | 5,864 | 27,007 | 117,453 | 73,058 |
Basic Shares | 25,505 | 23,817 | 19,712 | 19,738 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.24 |
2024-06-30 | -$0.26 |
2024-03-31 | -$0.29 |
2023-12-31 | -$0.27 |
